Literature DB >> 3275093

Measurements of serum-free thyroid hormone concentrations by ultrafiltration--a comparison with equilibrium dialysis and mathematical calculation.

N Konno1, K Hagiwara, H Taguchi, S Murakami, S Taguchi.   

Abstract

An ultrafiltration method (UF) for measuring free thyroxine (FT4) and free triiodothyronine (FT3) using the Diaflow YM membrane (Centricon-10) is described. The results are compared with those by equilibrium dialysis (ED) and also by mathematical calculations derived from T4, T3, and binding protein concentrations. The precision with the UF method was excellent. The normal ranges of FT4 and FT3 by the three methods are all comparable. There was a high degree of correlation of FT4 or FT3 results by UF with those by ED and by calculation (r = 0.940-0.974, n = 161, P less than 0.001). FT4 and FT3 by all methods agreed well for hyperthyroidism, hypothyroidism, and for patients with low T4-binding globulin. The mean FT3 in pregnancy was lower than the normal value for all methods, and FT4 concentrations by UF and calculation also decreased in late pregnancy. The mean FT4 by UF and ED in low T3 syndrome were significantly higher than in the normal controls, while the calculated FT4 was lower. The FT3 in low T3 syndrome distributed normal to subnormal in all methods. These results indicate that a) the UF method is a reliable reference method for measuring FT4 and FT3 concentrations; b) the UF results agree well with those by ED and also with theoretically derived values in subjects with thyroid diseases and TBG abnormalities; c) for patients with low T3 syndrome, the FT4 results obtained by UF and ED are similarly discrepant from the calculated results, implying the existence of binding inhibitor(s) which affect both UF and ED measurements.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3275093     DOI: 10.1007/bf03164545

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  31 in total

1.  Serum thyroid hormone binding inhibitor in nonthyroidal illnesses.

Authors:  I J Chopra; T S Huang; A Beredo; D H Solomon; G N Chua Teco
Journal:  Metabolism       Date:  1986-02       Impact factor: 8.694

2.  Ultrafiltration method for direct radioimmunoassay measurement of free thyroxine and free tri-iodothyronine in serum.

Authors:  J Weeke; N Boye; H Orskov
Journal:  Scand J Clin Lab Invest       Date:  1986-06       Impact factor: 1.713

3.  A new theoretical description of the binding of thyroid hormones by serum proteins.

Authors:  H P Princé; D B Ramsden
Journal:  Clin Endocrinol (Oxf)       Date:  1977-10       Impact factor: 3.478

4.  Free thyroxine in human serum: simplified measurement with the aid of magnesium precipitation.

Authors:  K Sterling; M A Brenner
Journal:  J Clin Invest       Date:  1966-01       Impact factor: 14.808

5.  Simulation of the thyroid hormone-binding protein interactions in human plasma.

Authors:  R D Brennan; F E Yates
Journal:  J Clin Endocrinol Metab       Date:  1970-06       Impact factor: 5.958

6.  Thyroxine-protein interactions. IV. Thermodynamic values for the association of thyroxine with human serum albumin.

Authors:  M Tabachnick
Journal:  J Biol Chem       Date:  1967-04-10       Impact factor: 5.157

7.  On the albumin-dependence of measurements of free thyroxin. II. Patients with non-thyroidal illness.

Authors:  G Csako; M H Zweig; C Benson; M Ruddel
Journal:  Clin Chem       Date:  1987-01       Impact factor: 8.327

8.  An improved ultrafiltration method for free thyroxine and triiodothyronine in serum.

Authors:  J Sophianopoulos; I Jerkunica; C N Lee; D Sgoutas
Journal:  Clin Chem       Date:  1980-01       Impact factor: 8.327

9.  Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine.

Authors:  N Konno; K Morikawa
Journal:  J Clin Endocrinol Metab       Date:  1982-06       Impact factor: 5.958

10.  Slow thyroxine binding globulin in the pathogenesis of increased dialysable fraction of thyroxine in nonthyroidal illnesses.

Authors:  C P Reilly; M L Wellby
Journal:  J Clin Endocrinol Metab       Date:  1983-07       Impact factor: 5.958

View more
  3 in total

1.  When thyroidologists agree to disagree: comments on the 2012 Endocrine Society pregnancy and thyroid disease clinical practice guideline.

Authors:  Offie P Soldin
Journal:  J Clin Endocrinol Metab       Date:  2012-08       Impact factor: 5.958

Review 2.  Thyroid hormone testing by tandem mass spectrometry.

Authors:  Offie P Soldin; Steven J Soldin
Journal:  Clin Biochem       Date:  2010-08-04       Impact factor: 3.281

Review 3.  Defending plasma T3 is a biological priority.

Authors:  Sherine M Abdalla; Antonio C Bianco
Journal:  Clin Endocrinol (Oxf)       Date:  2014-08-07       Impact factor: 3.478

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.